Alvotech and STADA add to strategic alliance through denosumab partnership
June 11, 2024 04:00 ET
|
Alvotech
STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central...
Alvotech og STADA útvíkka samstarf sitt með nýjum samningi um AVT03, fyrirhugaða hliðstæðu við Prolia og Xgeva
June 11, 2024 04:00 ET
|
Alvotech
Alvotech (NASDAQ: ALVO) og STADA tilkynntu í dag að fyrirtækin hafi útvíkkað samstarf sitt með samningi um markaðssetningu AVT03, fyrirhugaðrar líftæknilyfjahliðstæðu við Prolia og Xgeva (denosumab)...
Alvotech and STADA add to Strategic Alliance through Denosumab Partnership
June 11, 2024 04:00 ET
|
Alvotech
STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central...
InterDigital and Philips to Showcase Volumetric Streaming Technologies Empowering Immersive Sports Experiences at AWE USA 2024
June 11, 2024 04:00 ET
|
InterDigital, Inc.
InterDigital and Philips to demo volumetric video-based codecs, haptic innovation, and streaming technologies empowering immersive sports experiences
Lilium reports significant progress in Q1 2024 Shareholder Letter
June 11, 2024 04:00 ET
|
Lilium GmbH
MUNICH, Germany, June 11, 2024 (GLOBE NEWSWIRE) -- Lilium N.V. (Nasdaq: LILM) (“Lilium” or the “Company”), a leading electric aircraft manufacturer and pioneer in Regional Air Mobility (RAM), has...
Himax to Make Strategic Investment in FOCI Private Placement Financing; Companies to Unite FOCI’s World Leading CPO Technology with Himax State-of-the-Art Nano-Scale WLO at the Innovative Forefront of MCM Integration
June 11, 2024 02:20 ET
|
Himax Technologies, Inc.
HSINCHU and TAINAN, Taiwan, June 11, 2024 (GLOBE NEWSWIRE) -- FOCI Fiber Optic Communications, Inc. (TPEX: 3363) (“FOCI”), announced today that its Board of Directors has approved the issuance of...
Feutune Light Acquisition Corporation Announces that It Will Adjourn the Special Meeting of Stockholders to Approve Business Combination with Thunder Power Holdings Limited to June 17, 2024
June 11, 2024 01:00 ET
|
Feutune Light Acquisition Corporation
Special meeting of Feutune Light Acquisition Corporation stockholders to be adjourned until June 17, 2024, at 9:00 a.m., Eastern Time Wilmington, DE, June 11, 2024 (GLOBE NEWSWIRE) -- Feutune...
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024
June 11, 2024 01:00 ET
|
Molecular Partners
MP0712, a 212Pb-Radio-DARPin targeting DLL3, as first candidate of Molecular Partners’ RDT platform in development in partnership with Orano MedPositive tumor to kidney ratio and biodistribution,...
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 10, 2024 18:35 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted...
Centurion Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering
June 10, 2024 18:15 ET
|
Centurion Acquisition Corp.
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Centurion Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 25,000,000 units at a price of $10.00 per unit....